Study Title
Biomet
Purpose
Determine the safety and efficacy of the Comprehensive Shoulder System with Nano humerol component in total shoulder arthroplasty
Eligibility
Contact Principal Investigator for Information
Study Process
Patients age 21-90years old with non-inflammatory degenerative joint disease requiring total shoulder arthroplasty will be enrolled. Patients will be randomly assigned to have either the Comprehensive Shoulder System with Nano humerol component or the Comprehensive Shoulder System with mini-stem component implanted. Quality of life questionnaires will be completed at each visit.
Trial Details
Investigator:
Patrick Massey, M.D.
IRB:
Willis-Knighton
IRB Number:
Trial Type:
Device
Sponsor:
Biomet
Contact Information: